Is liver fibrosis reversible?

Gut

Volumn 46, Issue 4, 2000, Pages 443-446

  Benyon, R C ^a   Iredale, J P ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN; COLLAGENASE; COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

CELL SURVIVAL; CHRONIC LIVER DISEASE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STELLATE CELL;

ANIMALS; APOPTOSIS; COLLAGEN; COLLAGENASES; EXTRACELLULAR MATRIX; HUMANS; LIVER; LIVER CIRRHOSIS; METALLOENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034100952     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.4.443     Document Type: Review

References (55)

1. 1 Dufour JF, DeLellis R, Kaplan MM. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci 1998;43:2573-6.
2. 2 Dufour JF, DeLellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-5.
3. 3 Niederau C, Fischer R, Sonnenberg, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
4. 4 Sobesky R, Mathurin P, Charlotte F, et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology 1999;116:378-86.
5. 5 Benyon RC, Arthur MJ. Mechanisms of hepatic fibrosis. J Pediatr Gastroenterol Nutr 1998;27:75-85.
6. 6 Burt AD. Cellular and molecular aspects of hepatic fibrosis. J Pathol 1993; 170:105-14.
7. 7 Burt AD, Griffiths MR, Schuppan D, et al. Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling. Histopathology 1990;16:53-8.
8. 8 Schuppan D. Structure of extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990;10:1-10.
9. 9 Gressner AM, Haarmann R. Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture. Biochem Biophys Res Commun 1988;151:222-9.
10. 10 Hahn EG, Wick G, Pencev DT, et al. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV laminin and fibronectin. Gut 1980;21:63-71.
11. 11 Rojkind M, Giambrone M-A, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979;76:710-19.
12. 12 Seyer JM, Huherson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977;59:241-8.
13. 13 McGuire RF, Bissell DM, Boyles J, et al. Role of extracellular matrix in regulating fenestrations of endothelial cells isolated from normal rat liver. Hepatology 1992;15:989-97.
14. 14 Bissell DM, Caron JM, Babiss LE, et al. Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix. Mol Biol Med 1990;7:187-97.
15. 15 Bissell DM, Arenson DM, Maher JJ, et al. Support of cultured hepatocytes by a laminin-rich gel. J Clin Invest 1987;79:801-12.
16. 16 Friedman SL, Roll FJ, Boyles J, et al. Maintenance of differentiated pheno-type of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989;264:10756-62.
17. 17 Arthur MJP. Matrix degradation in liver: A role in injury and repair. Hepatology 1997;26:1069-71.
18. 18 Ohuchi E, Imai K, Fujii Y, et al. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51.
19. 19 Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase - inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995;270:5872-6.
20. 20 Perez-Tamayo R, Montfort I, Gonzalez E. Collagenolytic activity in experimental cirrhosis of the liver. Exp Mol Pathol 1987;47:300-8.
21. 21 Okazaki I, Maruyama K. Collagenase activity in experimental hepatic fibrosis. Nature 1974;252:49-50.
22. 22 Maruyama K, Feinman L, Fainsilber Z, et al. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci 1982;30:1379-84.
23. 23 Montfort I, Perez-Tamayo R. Collagenase in experimental carbon tetrachloride cirrhosis of the liver. Am J Pathol 1978;92:411-20.
24. 24 Takahashi S, Dunn MA, Seifter S. Liver collagenase in murine schistosomiasis. Gastroenterology 1980;78:1425-31.
25. 25 Benyon RC, Iredale JP, Goddard S, et al. Expression of tissue inhibitor of metalloproteinases-1 and -2 in increased in fibrotic human liver. Gastroenterology 1996;110:821-31.
26. 26 Iredale JP, Benyon RC, Arthur MJP, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176-84.
27. 27 Iredale JP, Goddard S, Murphy G, et al. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995;89:75-81.
28. 28 Zhang K, Rekhter MD, Gordon D, et al. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis - A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994;145:114-25.
29. 29 Kossakowska AE, Edwards DR, Lee SS, et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 1998;153:1895-902.
30. 30 Lichtinghagen R, Breitenstein K, Arndt B, et al. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch 1998;432:153-8.
31. 31 Knittel T, Mehde M, Kobold D, et al. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta 1. J Hepatol 1999; 30:48-60.
32. 32 Iredale JP, Murphy G, Hembry RM, et al. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP-1): Implications for regulation of matrix degradation in liver. J Clin Invest 1992;90:282-7.
33. 33 Herbst H, Wege T, Milani S, et al. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 1997; 150:1647-59.
34. 34 Milani S, Herbst H, Schuppan D, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144:528-37.
35. 35 Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS 1999;107:38-44.
36. 36 Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14:455-63.
37. 37 Leyland H, Gentry J, Arthur MJP, et al. The plasminogen-activating system in hepatic stellate cells. Hepatology 1996;24:1172-8.
38. 38 Knittel T, Fellmer P, Ramadori G. Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology 1996;111:745-54.
39. 39 Carmeliet P, Collen D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res 1998;91:255-85.
40. 40 Abdel-Aziz G, Lebeau G, Rescan PY, et al. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990;137:1333-42.
41. 41 Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-49.
42. 42 Baker AJ, Mooney A, Hughes J, et al. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94:2105-16.
43. 43 Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-9.
44. 44 Desmouliere A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
45. 45 Saile B, Knittel T, Matthes N, et al. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol 1997;151:1265-72.
46. 46 Gong W, Pecci A, Roth S, et al. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998;28:492-502.
47. 47 Nilsson G, Forsberg NK, Xiang Z, et al. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997;27:2295-301.
48. 48 Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26.
49. 49 Iwamoto H, Sakai H, Tada S, et al. Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion. J Lab Clin Med 1999;134:83-9.
50. 50 Mirza A, Liu SL, Frizell E, et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol 1997;272:G281-8.
51. 51 Ricard BS, Bresson HS, Guerret S, et al. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology 1996;111:172-82.
52. 52 Carter EA, McCarron MJ, Alpert E, et al. Lysyl oxidase and collagenase in experimental acute and chronic liver injury. Gastroenterology 1982;82:526-34.
53. 53 Vater CA, Harris-ED J, Siegel RC. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J 1979;181:639-45.
54. 54 Piacentini M, Autuori F, Dini L, et al. "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation. Cell Tissue Res 1991;263: 227-35.
55. 55 Jarnagin WR, Rockey DC, Koteliansky VE, et al. Expression of variant fibronectins in wound healing: Cellular sources and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-48.